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OBJECTIVES To determine whether catheter ablation is safe and effective in patients over the age of 80.
BACKGROUND There is a tendency to withhold invasive therapy in the elderly until it has been proven safe
and effective.
METHODS Over a two-year period from February 1, 1996 to February 1, 1998, 695 consecutive patients
underwent 744 catheter ablation procedures of supraventricular and ventricular arrhythmias.
These patients were divided into three groups based on age: $80 years, 60 to 79 years and
,60 years. Acute ablation success, using standard criteria and complication rates for these
three groups were determined.
RESULTS There were 37 patients $80 years, 275 patients 60 to 79 years and 383 patients ,60 years old.
The overall acute ablation success rate for the entire group was 95% with no difference in rates
among the three groups (97%, $80 years; 94%, 60–79 years; 95%, ,60 years). The
percentage of patients undergoing His bundle ablation was greatest in the $80-year-old
group (43% vs. 19% vs. 2%, p , 0.01), and the percentage of patients undergoing accessory
pathway ablation was greatest in the ,60-year-old patients (0% vs. 4% vs. 25%, p , 0.01).
The overall complication rate for the entire group was 2.6%, and there was only one
major/life-threatening complication. There was no difference in complication rates among the
groups (0%, $80 years; 2.2%, 60 to 79 years; 3.1%, ,60 years). Based on the sample size, the
95% confidence interval is 0% to 7.8% for an adverse event in the octogenarian.
CONCLUSIONS Catheter ablative therapy for the arrhythmias attempted in the very elderly appears to be
effective with low risk. Ablation results appear to be comparable with those noted in younger
patients. (J Am Coll Cardiol 2000;35:458–62) © 2000 by the American College of
Cardiology
There is a tendency to withhold invasive therapy in the
elderly until it has been proven safe and effective in younger
patients. Radiofrequency catheter ablation for supraventric-
ular and ventricular arrhythmias has been shown to be
effective. Success rates for eliminating atrioventricular (AV)
nodal reentry and AV reentry involving accessory pathways
(APs) have been reported to exceed 90% to 95% (1–3).
Successful ablation of the His bundle to control rapid
ventricular rates in response to atrial fibrillation and flutter
also exceeds 95% (4). Complications associated with these
ablative procedures occur at a low incidence of 2% to 5%
(1–7). To date, published series on the outcome with
ablation have included only small numbers of octogenarians.
The purpose of our investigation was to determine whether
catheter ablation is safe and effective in patients over the age
of 80.
METHODS
We prospectively assessed acute outcome and complications
for all catheter ablation procedures for supraventricular and
ventricular arrhythmias performed at a single teaching
institution with an active fellowship program in a two-year
period between February 1, 1996, and February 1, 1998.
Patients undergoing ablation were grouped according to
age—$80, 60 to 79 and ,60 years.
We classified the ablation types depending upon the
arrhythmias initiated using standard electrophysiologic
techniques and definitions. The arrhythmia types include:
AV nodal reentrant tachycardia (AVNRT) both typical and
atypical, AV reentrant tachycardia involving an AP either
concealed or manifest, atrial flutter including clockwise or
counterclockwise right atrial flutter, atrial tachycardia in-
cluding inappropriate sinus tachycardia and focal or macro-
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reentrant atrial tachycardia, atrial fibrillation with His bun-
dle ablation or AV node modification for ventricular rate
control and ventricular tachycardia (VT) in patients with
and without structural heart disease.
Ablation procedures were performed using standard map-
ping and ablative techniques that have been previously
described (8,9). With the exception of atrial flutter, radio-
frequency energy was applied through the 4 mm tip of the
ablation catheter. For atrial flutter, an 8 mm tip catheter was
used for most procedures. Radiofrequency energy was typ-
ically delivered at a power necessary to achieve an imped-
ance drop of 4 to 10 ohms or temperature increase from 50°
to 65°C. Radiofrequency energy was applied from 30 s to 2
minutes during continuous electrocardiographic and inter-
mittent fluoroscopic monitoring. Additional monitoring
using intracardiac echocardiographic imaging or nonfluoro-
scopic magnetic imaging (CARTO-Biosense, New Bruns-
wick, New Jersey) was used in 27 and 57 patients, respec-
tively.
Patients were brought routinely to the electrophysiology
laboratory in the postabsorptive state. Conscious sedation
was administered with continuous monitoring of blood
pressure, oxygen saturation and body surface electrocardio-
gram. Detailed electrophysiologic evaluation was performed
using standard stimulation and recording techniques to
establish the correct diagnosis and identify the appropriate
site for ablation. Acute ablation success was defined based
on arrhythmia type as follows: AVNRT—inability to initi-
ate more than single AV node “echoes” with and without
isoproterenol; atrial tachycardia—inability to reinitiate after
radiofrequency energy application; sinus node ablation for
inappropriate sinus tachycardia—decrease (.30 beats/min)
in maximum heart rate on isoproterenol and change in
P wave morphology in lead 3 to an inverted or flattened
P wave; atrioventricular reentry—absence of antegrade and
retrograde conduction over the AP with and without iso-
proterenol; atrial flutter—conduction block through the
inferior vena cava tricuspid valve (IVC-TV) isthmus as
determined by HALO or CARTO recordings or His-
coronary sinus (CS) reversal (10); His bundle ablation—
complete heart block. One patient underwent AV modifi-
cation for rate control of atrial fibrillation and demonstrated
a decrease in the mean ventricular response to atrial fibril-
lation to ,100 beats/min on isoproterenol. Ventricular
tachcardia—inability to reinitiate targeted tachycardia mor-
phology. Programmed stimulation was also performed on
isoproterenol in patients without structural heart disease.
Thirty-five patients (9%) underwent ablation of two
arrhythmia types (i.e., AVNRT and AP) at the same or two
different procedures. These patients were counted once in
each type of ablation procedure.
Complications. Complications were grouped into three
categories according to the seriousness or permanence of the
event.
1) Major or life-threatening complications: death, myo-
cardial infarction, bradycardia-dependent polymorphic
VT (as described in patients following His bundle
ablation), embolic stroke involving transient or perma-
nent neurologic alteration, persistent unintentional
heart block (second or third degree), valve disruption
defined as any new regurgitant lesion in either the
mitral or aortic valves, and pulmonary embolus.
2) Serious complications: deep venous thrombosis, retro-
peritoneal bleeding and pericardial effusion requiring
drainage.
3) Minor complications: hematoma, defined as a sizable
(.5 3 5 cm) collection or blood loss sufficient to cause
a .1 g hemoglobin drop whether or not transfusion
was required, oversedation resulting in altered mental
status and early termination of the procedure and
ischemic chest pain without infarction (angina) that
necessitated interruption of the procedure for evalua-
tion and treatment.
Events that did not result in early termination/failure of
the procedure, patient compromise or prolonged hospital-
ization were not included in analysis. Examples of such
events include transient hypotension that responded to fluid
resuscitation and minor vagal reaction.
Statistical analysis. Results are presented as mean 6 SD
where appropriate. Success rates and incidence of compli-
cations were compared using 2 3 3 contingency table with
a p value ,0.05 considered significant. The one-sided, 95%
binomial confidence interval for an adverse event in the
octogenarian was also determined. Finally, we performed a
post hoc analysis to determine the power to detect an
increase in risk of complications in octogenarians of greater
than 10% when compared with the risk identified in the
population ,80 years of age.
RESULTS
Six hundred and ninety-five patients underwent 744 abla-
tion procedures. The mean age was 54 6 18 years and
included 368 men (53%). Table 1 presents the demographic
information of the three age groups. The groups were
similar with respect to gender distribution. Ablations were
performed for AVNRT in 221 patients, for APs in 101
patients, for atrial flutter in 157 patients, for atrial tachy-
cardia in 73 patients, for His bundle ablation in 75 patients
Abbreviations and Acronyms
AP 5 accessory pathway
AV 5 atrioventricular
AVNRT 5 atrioventricular nodal reentrant tachycardia
CS 5 coronary sinus
IVC-TV 5 inferior vena cava tricuspid valve
VT 5 ventricular tachycardia
459JACC Vol. 35, No. 2, 2000 Zado et al.
February 2000:458–62 Catheter Ablation in Octogenarians
and for VT in 68 patients. Forty-eight patients (7%)
underwent two or more procedures because of an unsuc-
cessful first procedure (10 patients) or late recurrence of the
arrhythmia (38 patients). Table 2 categorizes the incidence
of short-term success by arrhythmia type in each of the age
groups. There was no difference in the success rates among
the three groups in arrhythmia types with more than five
patients represented. The age groups did differ in their
make-up with respect to arrhythmia type (Table 3). Patients
.60 years of age underwent significantly more AP ablations
than either the 60 to 79 year age group or the $80 year age
group (p , 0.01). The $80 year age group underwent
significantly more His bundle ablations (43%) than either
the 60 to 79 year group (19%) or the ,60 age group (2%),
p , 0.01. Only a small number of patients in the $80 age
group underwent ablation procedures for atrial tachycardia,
VT and APs.
Eighteen of the 695 patients (2.6%) experienced compli-
cations while undergoing 744 catheter ablation procedures
(Table 4). Six patients with pericardial effusions were
drained percutaneously, and one patient required surgical
drainage because of recurrent effusion. The episode of deep
venous thrombosis was not complicated by pulmonary
embolus. None of the patients with hematomas required a
blood transfusion. There were no obvious sequelae in two
patients that were oversedated or three that developed
angina requiring termination of the procedure. The single
patient with embolic stroke was the only one who experi-
enced any long-term adverse sequelae from the catheter
ablative procedure.
Complications occurring in each of the age groups are
listed in Table 4. There was no difference in the incidence
of complications among the three age groups (0% vs. 2.2%
vs. 3.1%, p 5 NS). The upper limit of the 95% confidence
interval for an adverse event in the octogenarian is 7.8%. In
addition, based on the described sample size, the power to
detect an increase in complication rate in octogenarians
from 2.8% (risk in patients ,80 years of age) to .10% was
61% with an alpha of 0.05 (two-tailed).
DISCUSSION
Efficacy of catheter ablation in elderly patients. Ablative
therapy has traditionally been withheld from the very elderly
because it is an invasive procedure with small but well
defined risks that might be anticipated to be higher than
those observed in younger patients. In addition, the success
rates of catheter ablative therapy for the arrhythmias that
occur in the very elderly have not been firmly established.
Catheter ablative therapy is frequently withheld despite the
fact that with advancing age the frequency of symptomatic
episodes of supraventricular tachycardia and atrial fibrilla-
tion increase and antiarrhythmic drugs are poorly tolerated
(11–14). Our results establish that successful ablation of the
described arrhythmias which are commonly seen in the very
elderly can be achieved with the same high success rate
(.95%) and low risk achieved in younger patients. Impor-
tantly, we purposely divided our patients into three age
groups but could not determine a graded increase in risk or
reduction in anticipated success with advancing age.
Comparison with previous studies. Patients in this anal-
ysis were separated into three age groups to permit a closer
comparison with previous reports in which the influence of
age on outcome with catheter ablation was assessed. Epstein
et al. (14) reported on the outcome of 68 patients over the
age of 70. The number of patients over 80 was not stated,
but the mean age ranged from 72 to 77 years depending on
the arrhythmia type. These investigators noted that success
rates for ablative therapy were also comparable with those
reported in younger patients. Of note, similar to our
Table 1. Group Demographics
Group >80 yrs 60–79 yrs <60 years Total Group
Number of patients 37 275 383 695
Mean age (yrs) 83 6 2.4 69 6 5.3 41 6 13.3 54 6 18
Age range (yrs) 80–96 60–79 12–59 12–96
Males (%) 16 (43%) 156 (57%) 197 (51%) 368 (53%)
Table 2. Short-Term Success Rates of Different Arrhythmia Types for the Total Group and in
the Three Age Groups
>80 60–79 <60 Total Group
AVNRT 11/11 (100%) 78/78 (100%) 130/132 (98%) 219/221 (99%)
Accessory pathway 0 11/12 (92%) 95/98 (96%) 97/101 (96%)
Atrial tachycardia 1/1 18/23 (78%) 41/49 (84%) 60/73 (82%)
Atrial flutter 6/6 (100%) 83/85 (98%) 65/66 (98%) 154/157 (98%)
His bundle 16/16 (100%) 50/52 (96%) 7/7 (100%) 73/75 (97%)
VT 2/3 18/25 (72%) 37/40 (93%) 57/68 (84%)
Totals 36/37 (97%) 258/275 (94%) 365/383 (95%) 659/695 (95%)
AVNRT 5 atrioventricular nodal reentry; VT 5 ventricular tachycardia.
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experience, all nine of their elderly patients undergoing
radiofrequency ablation of accessory pathways were less than
80 years. Chen et al. (15) also reported on the influence of
age on outcome with ablative therapy for AP and AV nodal
reentrant tachycardia ablation. Importantly, this study dem-
onstrated comparable success rates in younger and older
(.65 years old, mean age 69 years) patients. Our results
support the previous reports and suggest that success of
ablative therapy for the described arrhythmias should be
anticipated even when the procedure is performed on the
very elderly.
Complications. Our complication rate of 18 out of 695
(2.6%) patients and 18 out of 744 (2.4%) procedures is low
and is comparable with the incidence of complications
reported in other large series. Indeed, in our experience the
risk of life threatening complications was extremely low
(Table 4). Only one patient (0.2%), age 59, experienced a
stroke with residual right arm weakness following an abla-
tion for VT in the setting of chronic coronary artery disease.
Transatrial placement of the catheter was required because
of the extent of peripheral vascular disease, and it is believed
that thrombus associated with a transient impedance rise
during radiofrequency energy delivery was jettisoned free
when removing the catheter through the transseptal sheath
at the end of the ablation procedure. No other patient
experienced death, myocardial infarction, valve disruption,
Table 3. Percent of Patients in the Age Group with Each Arrhythmia Type
>80 60–79 <60 p Value
AVNRT 30% 28% 34% NS
Accessory pathway 0% 4% 25% , 0.01
Atrial tachycardia 3% 8% 12% NS
Atrial flutter 16% 31% 17% 0.05
His ablation 43% 19% 2% 0.01
VT 8% 10% 10% NS
AVNRT 5 atrioventricular nodal reentrant tachycardia; VT 5 ventricular tachycardia.
Table 4. Complications of Catheter Ablative Therapy and Overall Incidence in Study












Death 0 0 0 0
Myocardial infarction 0 0 0 0
Bradycardia-dependent PMVT 0 0 0 0
Embolic stroke 1 0 0 1
Persistent unintentional heart block 0 0 0 0
Valve disruption 0 0 0 0
Pulmonary embolus 0 0 0 0
Total major complications 1/695 0 0 1/383
(0.1%) (0%) (0%) (0.3%)
Serious
Deep venous thrombosis 1 0 0 1
Retroperitoneal bleeding 1 0 0 1
Pericardial effusion requiring drainage 7 0 2 5
Total serious complications 9/695 0 2/275 7/383
(0.9%) (0%) (0.7) (1.8%)
Minor
Hematoma 3 0 2 1
Over-sedation resulting in altered mental status 2 0 0 2
Ischemic chest pain without infarction (angina) 3 0 2 1
Total minor complications 8/695 0 4/275 4/383
(1.1%) (0%) (1.4%) (1.0%)
Total complications/patient (percentage) 18/695 0/37 6/275 12/383
(2.6%) (0%) (2.2%) (3.1%)
PMVT 5 polymorphic ventricular tachycardia.
461JACC Vol. 35, No. 2, 2000 Zado et al.
February 2000:458–62 Catheter Ablation in Octogenarians
heart block or pulmonary emboli. Our findings corroborate
the low risk of the catheter ablative procedure for right sided
ablative procedures in the elderly population (60 to 79 years)
and extend the results even in the very elderly ($80). The
two previous reports that addressed efficacy and risk asso-
ciated with catheter ablative therapy in the elderly suggested
a higher risk of ablative procedures for accessory pathways.
They noted complications in 2 of 9 (22%) and 4 of 29 (14%)
elderly patients with left sided accessory pathway ablations.
Of note, only one of the 20 left sided procedures in the 60
to 79 year range and none of the four left sided procedures
in the patients $80 years experienced a serious complica-
tion. A single patient developed a pericardial effusion.
Despite the low complication rate observed, a cautious
approach must be taken in the elderly patient undergoing
left sided ablative procedures. Vascular access is frequently
difficult and vigilance is required to minimize thromboem-
bolic and cardiac perforation risks.
Study limitations. The major limitation of this study is
related to the limited sample size of patients who were very
elderly who underwent ablation procedures for elimination
of atrial tachycardia, VT and AP. Thus, we need to refrain
from generalizing and indicating that ablative therapy is
effective and safe for all arrhythmia types in the very elderly
until more data are available for assessing efficacy and risk in
arrhythmias that occur less frequently in the elderly. In
addition, because of the relatively small number of patients
who were $80 years of age, one should be cautious about
concluding that there is no ablation risk in the octogenarian.
In fact, the power calculation of 61% for detecting an
increased complication risk to .10% suggests that the
sample size with respect to the number of octogenarians
represents a limitation of the study. Importantly, however,
confidence interval results have been reported to be a better
reflection of the precision of a study than the post hoc power
analysis (16). Based on the sample size, the 95% confidence
interval is 0% to 7.8% for an adverse event in the octoge-
narian. Therefore, at the very least, we can indicate with
confidence that the complication rate is likely to be less than
7.8% for octogenarians undergoing the described ablation
procedures based on our study results.
Conclusions. Catheter ablation for arrhythmia syndromes
that are common in the very elderly can be performed with
efficacy and risk profiles that are similar to those observed in
younger patients. Our results suggest that catheter ablative
therapy in the elderly for atrial flutter, AV nodal reentry and
atrial-ventricular junction ablation for rapid ventricular
response to atrial fibrillation should probably be considered
as an appropriate therapeutic option. The strategy used for
these arrhythmias should be independent of age. In fact,
given the potential for greater intolerance to drug therapy
coupled with the documented tendency for increased fre-
quency and severity with the arrhythmia episodes that occur
with aging, ablative therapy should be considered the initial
treatment of choice for many patients.
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